Identification of Hub Genes in Type 2 Diabetes Mellitus Using Bioinformatics Analysis

References

• Dogruel H, Balci MK. Development of therapeutic options on type 2 diabetes in years: glucagon-like peptide-1 receptor agonist’s role in treatment; from the past to future. World J Diabetes. 2019;10(8):446–453. doi:10.4239/wjd.v10.i8.446
   PubMedGoogle Scholar
• Zhong M, Wu Y, Ou W, Huang L, Yang L. Identification of key genes involved in type 2 diabetic islet dysfunction: a bioinformatics study. Biosci Rep. 2019;39(5). doi:10.1042/BSR20182172
   Google Scholar
• Brunetti A, Chiefari E, Foti D. Recent advances in the molecular genetics of type 2 diabetes mellitus. World J Diabetes. 2014;5(2):128–140. doi:10.4239/wjd.v5.i2.128
   PubMedGoogle Scholar
• Wang N, Zhu F, Chen L, Chen K. Proteomics, metabolomics and metagenomics for type 2 diabetes and its complications. Life Sci. 2018;212:194–202. doi:10.1016/j.lfs.2018.09.035
   PubMedGoogle Scholar
• Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2019;62(1):3–16. doi:10.1007/s00125-018-4711-2
   PubMed Web of Science ®Google Scholar
• Ashcroft FM, Rorsman P. Diabetes mellitus and the beta cell: the last ten years. Cell. 2012;148(6):1160–1171. doi:10.1016/j.cell.2012.02.010
   PubMed Web of Science ®Google Scholar
• Jia K, Wu Y, Ju J, et al. The identification of gene signature and critical pathway associated with childhood-onset type 2 diabetes. PeerJ. 2019;7:e6343. doi:10.7717/peerj.6343
   PubMedGoogle Scholar
• Ding LC, Fan L, Xu XD, Fu JF, Xue YD. Identification of core genes and pathways in type 2 diabetes mellitus by bioinformatics analysis. Mol Med Rep. 2019;20(3):2597–2608. doi:10.3892/mmr.2019.10522
   PubMedGoogle Scholar
• Taneera J, Fadista J, Ahlqvist E, et al. Identification of novel genes for glucose metabolism based upon expression pattern in human islets and effect on insulin secretion and glycemia. Hum Mol Genet. 2015;24(7):1945–1955. doi:10.1093/hmg/ddu610
   PubMed Web of Science ®Google Scholar
• Taneera J, Lang S, Sharma A, et al. A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets. Cell Metab. 2012;16(1):122–134. doi:10.1016/j.cmet.2012.06.006
   PubMed Web of Science ®Google Scholar
• Taneera J, Fadista J, Ahlqvist E, et al. Expression profiling of cell cycle genes in human pancreatic islets with and without type 2 diabetes. Mol Cell Endocrinol. 2013;375(1–2):35–42. doi:10.1016/j.mce.2013.05.003
   PubMedGoogle Scholar
• Edgar R, Domrachev M, Lash AE. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30(1):207–210. doi:10.1093/nar/30.1.207
   PubMed Web of Science ®Google Scholar
• Ashburner M, Ball CA, Blake JA, et al. Gene Ontology: tool for the unification of biology. Nat Genet. 2000;25(1):25–29. doi:10.1038/75556
   PubMed Web of Science ®Google Scholar
• Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27–30. doi:10.1093/nar/28.1.27
   PubMed Web of Science ®Google Scholar
• Jiao XL, Sherman BT, Huang DW, et al. DAVID-WS: a stateful web service to facilitate gene/protein list analysis. Bioinformatics. 2012;28(13):1805–1806. doi:10.1093/bioinformatics/bts251
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Franceschini A, Wyder S, et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43(Database issue):D447–52. doi:10.1093/nar/gku1003
   PubMed Web of Science ®Google Scholar
• Saito R, Smoot ME, Ono K, et al. A travel guide to cytoscape plugins. Nat Methods. 2012;9(11):1069–1076. doi:10.1038/nmeth.2212
   PubMed Web of Science ®Google Scholar
• Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8(Suppl 4):S11. doi:10.1186/1752-0509-8-S4-S11
   PubMed Web of Science ®Google Scholar
• Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus–present and future perspectives. Nat Rev Endocrinol. 2011;8(4):228–236. doi:10.1038/nrendo.2011.183
   PubMed Web of Science ®Google Scholar
• Fonseca VA. Identification and treatment of prediabetes to prevent progression to type 2 diabetes. Clin Cornerstone. 2007;8(2):10–8; discussion 19–20. doi:10.1016/S1098-3597(09)60004-1
   Google Scholar
• Zhao QQ, Zhang AH, Zong WJ, et al. Exploring potential biomarkers and determining the metabolic mechanism of type 2 diabetes mellitus using liquid chromatography coupled to high-resolution mass spectrometry. RSC Adv. 2017;7(70):44186–44198. doi:10.1039/C7RA05722A
   Web of Science ®Google Scholar
• Zhou H, Zhang WC. Gene expression profiling reveals candidate biomarkers and probable molecular mechanism in diabetic peripheral neuropathy. Diabetes Metab Syndr. 2019;12:1213–1223. doi:10.2147/DMSO.S209118
   Google Scholar
• Li L, Lei QS, Zhang SJ, Kong LN, Qin B. Screening and identification of key biomarkers in hepatocellular carcinoma: evidence from bioinformatic analysis. Oncol Rep. 2017;38(5):2607–2618. doi:10.3892/or.2017.5946
   PubMed Web of Science ®Google Scholar
• Xiong Y, Mi BB, Liu MF, Xue H, Wu QP, Liu GH. Bioinformatics analysis and identification of genes and molecular pathways involved in synovial inflammation in rheumatoid arthritis. Med Sci Monit. 2019;25:2246–2256. doi:10.12659/MSM.915451
   PubMed Web of Science ®Google Scholar
• Choy E, Rose-John S. Interleukin-6 as a multifunctional regulator: inflammation, immune response, and fibrosis. J Scleroderma Relat Disord. 2017;2(2_suppl):S1–S5.
   Google Scholar
• Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014;6(10):a016295. doi:10.1101/cshperspect.a016295
   PubMed Web of Science ®Google Scholar
• Qu D, Liu J, Lau CW, Huang Y. IL-6 in diabetes and cardiovascular complications. Br J Pharmacol. 2014;171(15):3595–3603. doi:10.1111/bph.12713
   PubMed Web of Science ®Google Scholar
• Giulietti A, van Etten E, Overbergh L, Stoffels K, Bouillon R, Mathieu C. Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory. Diabetes Res Clin Pract. 2007;77(1):47–57. doi:10.1016/j.diabres.2006.10.007
   PubMed Web of Science ®Google Scholar
• Woodrick RS, Ruderman EM. Interleukin 6 inhibition - RA and beyond. Bull NYU Hosp Jt Dis. 2011;69(3):225–229.
   PubMedGoogle Scholar
• Huth C, Heid IM, Vollmert C, et al. IL6 gene promoter polymorphisms and type 2 diabetes - joint analysis of individual participants’ data from 21 studies. Diabetes. 2006;55(10):2915–2921. doi:10.2337/db06-0600
   PubMedGoogle Scholar
• Fosgerau K, Galle P, Hansen T, et al. Interleukin-6 autoantibodies are involved in the pathogenesis of a subset of type 2 diabetes. J Endocrinol. 2010;204(3):265–273. doi:10.1677/JOE-09-0413
   PubMedGoogle Scholar
• Hamid YH, Rose CS, Urhammer SA, et al. Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes. Diabetologia. 2005;48(2):251–260. doi:10.1007/s00125-004-1623-0
   PubMedGoogle Scholar
• Bernal-Lopez MR, Llorente-Cortes V, Calleja F, et al. Effect of different degrees of impaired glucose metabolism on the expression of inflammatory markers in monocytes of patients with atherosclerosis. Acta Diabetol. 2013;50(4):553–562. doi:10.1007/s00592-011-0337-2
   PubMedGoogle Scholar
• Pleskovic A, Letonja MS, Vujkovac AC, et al. Matrix metalloproteinase-3 gene polymorphism (rs3025058) affects markers atherosclerosis in type 2 diabetes mellitus. Vasa. 2017;46(5):363–369. doi:10.1024/0301-1526/a000637
   PubMedGoogle Scholar
• van der Leeuw J, Beulens JWJ, van Dieren S, et al. Novel biomarkers to improve the prediction of cardiovascular event risk in type 2 diabetes mellitus. J Am Heart Assoc. 2016;5(6). doi:10.1161/JAHA.115.003048
   PubMedGoogle Scholar
• Deryugina EI, Quigley JP. Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature. Matrix Biol. 2015;44–46:94–112. doi:10.1016/j.matbio.2015.04.004
   PubMed Web of Science ®Google Scholar
• Pulukuri SMK, Rao JS. Matrix metalloproteinase-1 promotes prostate tumor growth and metastasis. Int J Oncol. 2008;32(4):757–765.
   PubMedGoogle Scholar
• Macarie RD, Vadana M, Ciortan L, et al. The expression of MMP-1 and MMP-9 is up-regulated by smooth muscle cells after their cross-talk with macrophages in high glucose conditions. J Cell Mol Med. 2018;22(9):4366–4376. doi:10.1111/jcmm.13728
   PubMed Web of Science ®Google Scholar
• Abu El-Asrar AM, Alam K, Nawaz MI, et al. Upregulation of thrombin/matrix metalloproteinase-1/protease-activated receptor-1 chain in proliferative diabetic retinopathy. Curr Eye Res. 2016;41(12):1590–1600. doi:10.3109/02713683.2016.1141964
   PubMed Web of Science ®Google Scholar
• Stoynev N, Dimova I, Rukova B, et al. Gene expression in peripheral blood of patients with hypertension and patients with type 2 diabetes. J Cardiovasc Med (Hagerstown). 2014;15(9):702–709. doi:10.2459/JCM.0b013e32835dbcc8
   PubMedGoogle Scholar
• Paul SR, Bennett F, Calvetti JA, et al. Molecular-cloning of a cDNA-encoding interleukin-11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc Natl Acad Sci USA. 1990;87(19):7512–7516. doi:10.1073/pnas.87.19.7512
   PubMed Web of Science ®Google Scholar
• Harmegnies D, Wang XM, Vandenbussche P, et al. Characterization of a potent human interleukin-11 agonist. Biochem J. 2003;375:23–32. doi:10.1042/bj20030459
   PubMedGoogle Scholar
• Liao CW, Hu SQ, Zheng ZH, Tong HZ. Contribution of interaction between genetic variants of interleukin-11 and helicobacter pylori infection to the susceptibility of gastric cancer. Once targets Ther. 2019;12:7459–7466. doi:10.2147/OTT.S214238
   PubMed Web of Science ®Google Scholar
• Schafer S, Viswanathan S, Widjaja AA, et al. IL-11 is a crucial determinant of cardiovascular fibrosis. Nature. 2017;552(7683):110-+. doi:10.1038/nature24676
   PubMedGoogle Scholar
• Nicolau J, Lequerre T, Bacquet H, Vittecoq O. Rheumatoid arthritis, insulin resistance, and diabetes. Joint Bone Spine. 2017;84(4):411–416. doi:10.1016/j.jbspin.2016.09.001
   PubMed Web of Science ®Google Scholar
• Niu X, Lu C, Xiao C, et al. The crosstalk of pathways involved in immune response maybe the shared molecular basis of rheumatoid arthritis and type 2 diabetes. PLoS One. 2015;10(8):e0134990. doi:10.1371/journal.pone.0134990
   PubMedGoogle Scholar